IPO News Archive

China Nuokang prices IPO at $9.00, below the range

12/10/09


China Nuokang Bio-Pharma, a leading provider of blood-clotting medication in China, raised $45 million by offering 5 million ADSs at $9.00, below the low end of the $10.00 to $12.00 proposed range. China Nuokang Bio-Pharma is expected to begin trading Thursday on the NASDAQ under the symbol NKBP. Jefferies acted as lead manager on the deal.

View IPO Profile: NKBP         
Source: www.RenaissanceCapital.com
Latest User Comments
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest